EUrOPA PROMpT: EU funding OPportunities and PROject Management Tips

Home » Scoop.it

Category Archives: Scoop.it

29 countries have earmarked funding for Eurostars-2 new submission deadline


Raising the productivity and competitiveness of European businesses through technology. Boosting national economies on the international market, and strengthening the basis for sustainable prosperity and employment

Source: www.eurekanetwork.org

Eurostars provides funding and support to research-performing companies, especially SMEs. In a Eurostars project, the R&D-performing SME takes a leading position in a transnational consortium.
Funding for Eurostars participants is provided on a country-by-country basis.

The following countries have dedicated funding for the next Eurostars-2 submission deadline, on September 11th, 2014:
Austria
France
Luxembourg
Sweden
Belgium
Germany
Malta
Switzerland
Bulgaria
Hungary
The Netherlands
Turkey
Croatia
Iceland
Norway
United Kingdom
Cyprus
Ireland
Poland
South Korea
Czech Republic
Israel
Romania
 
Denmark
Latvia
Slovak Republic
 
Finland
Lithuania
Spain
Advertisements

CALL ECSEL-2014-2 INNOVATION ACTIONS H2020


Source: coggle.it

Type of action: ECSEL Innovation Action

Description: Action primarily consisting of activities directly aiming at producing plans and arrangements or designs for new, altered or improved products, processes or services. For this purpose
they may include prototyping, testing, demonstrating, piloting, large-scale product validation and market replication.
A ‘demonstration or pilot’ aims to validate the technical and economic viability of a new or improved technology, product, process, service or solution in an operational (or near to operational) environment,
whether industrial or otherwise, involving where appropriate a larger scale prototype or demonstrator.
A ‘market replication’ aims to support the firstapplication/deployment in the market of an innovation that has already been demonstrated but not yet applied/deployed in the market due to market
failures/barriers to uptake. ‘Market replication’ does not cover multiple applications in the market of an innovation 4 that has already been applied successfully once in the market. ‘First’ means new at least to Europe or new at least to the application sector in question. Often such projects involve a validation of technical and economic performance at system level in real life operating conditions provided by the market.

Deadline Date17-09-2014 17:00:00


First Horizon 2020 Work Programme update – launch of FTI and innovation prizes


European Commission – Press Release details page – European Commission MEMO Brussels, 22 July 2013 The adoption today of the updated 2014-2015 Horizon 2020 Work Programme confirms the amounts for the actions to be implemented through next year’s budget – see table at the end of this document – and brings in two main novelties presented here: a

Source: europa.eu

Food-Scanner Prize

Prize money: €1 million

Timeline: Contest opens at the beginning of 2015 and runs until end of 2015

The objective is to unlock the eHealth market with solutions that support citizens in adopting a more active lifestyle and in improving their health by better monitoring food intake. The expected results are an eHealth solution that enables citizens to assess their food intake and provide optimal recommendations to improve their health and well-being. The solution should benefit a wide range of the EU population, from healthy citizens to citizens suffering from food disorders, obesity or allergies.

Calls for projects – EUREKA


Raising the productivity and competitiveness of European businesses through technology. Boosting national economies on the international market, and strengthening the basis for sustainable prosperity and employment

Source: www.eurekanetwork.org

Open calls:
  • Call for EUREKA individual projects. Dealdline OPEN ALL YEAR LONG
  • Bilateral call between Canada and Israel. Deadline OPEN ALL YEAR LONG
  • Multilateral call between France, Germany, Spain and United Kingdom. Deadline:DEADLINE AUGUST 1, 2014
  • Call for Eurostars-2 projects. DEADLINE SEPTEMBER 11, 2014
  • Multialteral call in energy between Austria, Germany and Switzerland. DEADLINE SEPTEMBER 19, 2014
  • Call for EUROGIA2020 projects. DEADLINE SEPTEMBER 22, 2014
  • Call for ACQUEAU projects. DEADLINE OCTOBER 1, 2014



H2020 Commission announces €100 million Fast Track to Innovation and five innovation prizes


European Commission – Press Release details page – European Press release Brussels, 22 July 2014 Commission The European Commission today presents details of a new €100 million “Fast Track to Innovation” (FTI) pilot action and five innovation prizes under Horizon 2020, the European Union’s €80 billion research and innovation programme. The FTI aims to support Europe’s economy by

Source: europa.eu

The contests for the five innovation prizes will start in late 2014 and early 2015.

The prizes, worth €6 million in 2015, cover three different thematic areas of research:

health:

  • “Reduction of the Use of Antibiotics Prize”,
  • “Food-Scanner Prize”

environment:

  • “Reduction of Air Pollution Prize”

 ICT :

  • “Collaborative Sharing of Spectrum”
  • “Optical Transmission Prize”.

HCO-12-2015 Call for proposal ERA NET: Antimicrobial resistance #H2020


Research Participant Portal is your entry point for electronic administration of EU-funded research and innovation projects

Source: ec.europa.eu

Specific challenge: Antibiotic resistance is a global problem. It is considered by the World Health Organization as one of the three greatest threats to human health for the next decades. In Europe, however, research on the resistance to antibiotics and on how to make sustainable use of antibiotics is fragmented. In addition, few countries have specific programs dedicated to this field of research.

The Joint Programming Initiative (JPI) on Anti-Microbial Resistance (AMR) provides an excellent opportunity for joint research of the EU Member States addressing the emerging problem of antibiotic resistance in human and veterinary medicine. Indeed, the currently funded research projects in national or trans-national programs are usually the result of calls initiated within other research areas rather than from research programmes specifically focusing on AMR. Consequently, the variable and non-permanent resources of trans-national organisations and individual countries are insufficient to provide the long-term funding opportunities that are required to solve the major research questions concerning AMR. In addition, research activities on AMR are not harmonised between countries; which may lead to duplications in the research being performed in different countries.

The 19 participating countries of the AMR JPI aim to accomplish the coordination of European research on AMR in close collaboration with the funding instruments of the EU; specifically Horizon 2020, Innovative Medicines Initiative (IMI) and the ERA-NET Infect-ERA.

This will create the necessary critical mass and develop the most advanced scientific approaches to tackle the problem of AMR, reversing its increasing trend, in the way forward defined by the Strategic Research Agenda which is to be adopted by the JPIAMR in early 2014.

This transnational cooperation will enhance the societal impact that is required in this area, promoting knowledge dissemination among multiple sectors of the society that are implicated – patients, clinical, veterinarians, pharmacists, food producers and representatives of the pharmaceutical industry.

Call for proposal HCO-13-2015 Health Co-ordination Activities Topic: ERA-NET: Cardiovascular disease


Research Participant Portal is your entry point for electronic administration of EU-funded research and innovation projects

Source: ec.europa.eu

Specific challenge: Cardiovascular diseases (CVD) are the largest cause of death in the EU and account for 40% of deaths or 2 million deaths per year. Overall CVD is estimated to cost the EU economy almost EUR 110 billion a year, and they are also one of the leading causes of long term sickness and loss to the labour market. CVD is therefore a major health problem in every country in Europe.

Scope: Proposals should coordinate national and regional programmes for research in the area cardiovascular research by implementing a transnational call with EU co-funding resulting in grants to third parties. Moreover, proposals should also aim at the better collaboration and alignment of national programmes and activities and should provide concrete plans for decreasing fragmentation, for data sharing, for addressing hurdles for effective coordination, for involving stakeholders and relevant existing initiatives. The Commission considers that proposals requesting a contribution from the EU of a minimum of EUR 5 million would allow this specific challenge to be addressed appropriately. Nonetheless, this does not preclude submission and selection of proposals requesting other amounts.

Expected impact:

·         Stepping up funding of transnational collaborative research projects in the area of cardiovascular research;

·         Identification of common research priorities and research needs, also taking into account developments on the international level where relevant;

·         Establishment and/or implementation of a common strategic research agenda;

·         Development and alignment of national and regional plans;

·         Streamlined national or regional practices in organising research funding;

·         Increased interoperability of national research programmes;

·         Prioritisation of transnational research;

·         Sharing of data and knowledge;

·         Networking of infrastructures and databases;

·         Contribution to the establishment of the ERA by addressing issues related for example to administrative hurdles, IPR management and different practices regarding resource sharing.



Deadline Date21-04-2015 17:00:00